Evidence map›Paper›PMID 27458202›Full record

ArticleNucleic acids research2016

eIF2β is critical for eIF5-mediated GDP-dissociation inhibitor activity and translational control.

Martin D Jennings, Christopher J Kershaw, Christopher White, Danielle Hoyle, Jonathan P Richardson, Joseph L Costello, Ian J Donaldson, Yu Zhou, Graham D Pavitt

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Protein Synthesis Initiation in Eukaryotic Cells.Cold Spring Harbor perspectives in biology · 2018
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Martin D JenningsFaculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.
Christopher J KershawFaculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.
Christopher WhiteFaculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.
Danielle HoyleFaculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.
Jonathan P RichardsonFaculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.
Joseph L CostelloFaculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.
Ian J DonaldsonFaculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.
Yu ZhouFaculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.
Graham D PavittFaculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK graham.pavitt@manchester.ac.uk.
Babraham Institute · GBUniversity of Exeter · GB

Funding

Biotechnology and Biological Sciences Research Council BB/G012571/1Biotechnology and Biological Sciences Research Council BB/H010599/1Medical Research Council MR/M008908/1
6 · The paper itself

Abstract

In protein synthesis translation factor eIF2 binds initiator tRNA to ribosomes and facilitates start codon selection. eIF2 GDP/GTP status is regulated by eIF5 (GAP and GDI functions) and eIF2B (GEF and GDF activities), while eIF2α phosphorylation in response to diverse signals is a major point of translational control. Here we characterize a growth suppressor mutation in eIF2β that prevents eIF5 GDI and alters cellular responses to reduced eIF2B activity, including control of GCN4 translation. By monitoring the binding of fluorescent nucleotides and initiator tRNA to purified eIF2 we show that the eIF2β mutation does not affect intrinsic eIF2 affinities for these ligands, neither does it interfere with eIF2 binding to 43S pre-initiation complex components. Instead we show that the eIF2β mutation prevents eIF5 GDI stabilizing nucleotide binding to eIF2, thereby altering the off-rate of GDP from eIF2•GDP/eIF5 complexes. This enables cells to grow with reduced eIF2B GEF activity but impairs activation of GCN4 targets in response to amino acid starvation. These findings provide support for the importance of eIF5 GDI activity in vivo and demonstrate that eIF2β acts in concert with eIF5 to prevent premature release of GDP from eIF2γ and thereby ensure tight control of protein synthesis initiation.

Indexed as

Protein BiosynthesisAmino Acid SequenceConserved SequenceEukaryotic Initiation Factor-2BEvolution, MolecularGuanine Nucleotide Dissociation InhibitorsGuanosine DiphosphateGuanosine TriphosphateModels, MolecularMutationProtein BindingProtein ConformationRepressor ProteinsRNA, TransferYeastsEukaryotic Initiation Factor-2BGuanine Nucleotide Dissociation InhibitorsGuanosine DiphosphateGuanosine TriphosphateRepressor ProteinsRNA, Transfer

Identifiers

PMID27458202
PMCPMC5175340
OpenAlexW2498336093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.